Eriocalyxin B, a Novel Autophagy Inducer, Exerts Anti-tumor Activity Through the Suppression of Akt/mTOR/p70S6K Signaling Pathway In breast Cancer
Xunian Zhou;  Grace Gar-Lee Yue;  Andrew Man-Lok Chan;   Stephen Kwok-Wing Tsui;  Kwok-Pui Fung;   Handong Sun;  Jianxin Pu;  Clara Bik-San Lau
2017
发表期刊Biochemical Pharmacology
卷号142页码:58–70
收录类别SCI
文献类型期刊论文
条目标识符http://ir.kib.ac.cn/handle/151853/54992
专题植物化学与西部植物资源持续利用国家重点实验室
推荐引用方式
GB/T 7714
Xunian Zhou;Grace Gar-Lee Yue;Andrew Man-Lok Chan; Stephen Kwok-Wing Tsui;Kwok-Pui Fung; Handong Sun;Jianxin Pu;Clara Bik-San Lau. Eriocalyxin B, a Novel Autophagy Inducer, Exerts Anti-tumor Activity Through the Suppression of Akt/mTOR/p70S6K Signaling Pathway In breast Cancer[J]. Biochemical Pharmacology,2017,142:58–70.
APA Xunian Zhou;Grace Gar-Lee Yue;Andrew Man-Lok Chan; Stephen Kwok-Wing Tsui;Kwok-Pui Fung; Handong Sun;Jianxin Pu;Clara Bik-San Lau.(2017).Eriocalyxin B, a Novel Autophagy Inducer, Exerts Anti-tumor Activity Through the Suppression of Akt/mTOR/p70S6K Signaling Pathway In breast Cancer.Biochemical Pharmacology,142,58–70.
MLA Xunian Zhou;Grace Gar-Lee Yue;Andrew Man-Lok Chan; Stephen Kwok-Wing Tsui;Kwok-Pui Fung; Handong Sun;Jianxin Pu;Clara Bik-San Lau."Eriocalyxin B, a Novel Autophagy Inducer, Exerts Anti-tumor Activity Through the Suppression of Akt/mTOR/p70S6K Signaling Pathway In breast Cancer".Biochemical Pharmacology 142(2017):58–70.
条目包含的文件 下载所有文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
22.pdf(5871KB)期刊论文作者接受稿开放获取CC BY-NC-SA浏览 下载
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Xunian Zhou;Grace Gar-Lee Yue;Andrew Man-Lok Chan; Stephen Kwok-Wing Tsui;Kwok-Pui Fung; Handong Sun;Jianxin Pu;Clara Bik-San Lau]的文章
百度学术
百度学术中相似的文章
[Xunian Zhou;Grace Gar-Lee Yue;Andrew Man-Lok Chan; Stephen Kwok-Wing Tsui;Kwok-Pui Fung; Handong Sun;Jianxin Pu;Clara Bik-San Lau]的文章
必应学术
必应学术中相似的文章
[Xunian Zhou;Grace Gar-Lee Yue;Andrew Man-Lok Chan; Stephen Kwok-Wing Tsui;Kwok-Pui Fung; Handong Sun;Jianxin Pu;Clara Bik-San Lau]的文章
相关权益政策
暂无数据
收藏/分享
文件名: 22.pdf
格式: Adobe PDF
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。